Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cc-11050
1. 340019-69-4
2. Cc-11050
3. 1z08g7438a
4. Cc11050
5. Cyclopropanecarboxamide, N-(2-((1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-2,3-dihydro-3-oxo-1h-isoindol-4-yl)-
6. Cyclopropanecarboxamide, N-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-3-oxo-1h-isoindol-4-yl]-
7. Refchem:124078
8. Unii-1z08g7438a
9. N-(2-((1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-3-oxo-2,3-dihydro-1h-isoindol-4-yl)cyclopropanecarboxamide
10. N-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-3-oxo-1h-isoindol-4-yl]cyclopropanecarboxamide
11. (s)-n-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-3-oxoisoindolin-4-yl)cyclopropanecarboxamide
12. Dovramilast [inn]
13. Schembl673303
14. Orb1686985
15. Chembl4297460
16. Schembl29366888
17. Schembl30701938
18. Gtpl13581
19. Amg-634
20. Qdzobxfrivoqbr-ljqanchmsa-n
21. Ex-a12042
22. Da-72891
23. Ms-28749
24. Hy-147263
25. Cs-0542404
26. H42759
27. Cyclopropyl-n-{2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindolin-4-yl}carboxamide
28. N-{2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2- (methanesulfonyl)ethyl]-3-oxo-2,3-dihydro-1h-isoindol- 4-yl}cyclopropanecarboxamide
29. N-{2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methanesulfonyl)ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}cyclopropanecarboxamide
| Molecular Weight | 472.6 g/mol |
|---|---|
| Molecular Formula | C24H28N2O6S |
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 9 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 110 |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 823 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Phosphodiesterase 4 Inhibitors
Compounds that specifically inhibit PHOSPHODIESTERASE 4.
ABOUT THIS PAGE
49
PharmaCompass offers a list of Dovramilast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Dovramilast manufacturer or Dovramilast supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dovramilast manufacturer or Dovramilast supplier.
A Dovramilast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dovramilast, including repackagers and relabelers. The FDA regulates Dovramilast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dovramilast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dovramilast supplier is an individual or a company that provides Dovramilast active pharmaceutical ingredient (API) or Dovramilast finished formulations upon request. The Dovramilast suppliers may include Dovramilast API manufacturers, exporters, distributors and traders.
Dovramilast Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dovramilast GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Dovramilast GMP manufacturer or Dovramilast GMP API supplier for your needs.
A Dovramilast CoA (Certificate of Analysis) is a formal document that attests to Dovramilast's compliance with Dovramilast specifications and serves as a tool for batch-level quality control.
Dovramilast CoA mostly includes findings from lab analyses of a specific batch. For each Dovramilast CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dovramilast may be tested according to a variety of international standards, such as European Pharmacopoeia (Dovramilast EP), Dovramilast JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dovramilast USP).
